Join Solidus Labs and industry experts for a debrief on ESMA’s latest Supervisory Briefing on the Authorisation of CASPs, published on 31 January 2025. Gain actionable insights to navigate MiCA authorization and ensure your firm is fully prepared to operate in the EU.

What’s Inside?

In this expert-led session, we break down:

• ESMA’s risk-based approach to CASP authorisation – How NCAs should assess intrinsic risk levels, prudential safeguards, and regulatory scrutiny in authorization applications.
• Governance, organisational structure & local presence requirements – Understanding the expectations for substance, control functions, and effective management oversight in host jurisdictions.
• Outsourcing arrangements and cross-border operations – Compliance considerations for third-party reliance, intra-group service agreements, and regulatory supervision across jurisdictions.
• Fit & proper requirements for members of the management body and key function holders – How NCAs evaluate integrity, competence, financial soundness, and conflicts of interest in leadership assessments.
• MiCA’s broader market impact and remaining implementation challenges in 2025 – Key supervisory priorities, transition considerations, and regulatory convergence across the EU.

Pre-register now to access the full on-demand webinar when it goes live on Monday, 31 March at 11am CET — and stay ahead of MiCA’s evolving landscape.